Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

Seifert Bryce A.; ODaniel Julianne M.; Amin Krunal; Marchuk Daniel S.; Patel Nirali M.; Parker Joel S.; Hoyle Alan P.; Mose Lisle E.; Marron Andrew; Hayward Michele C.; Bizon Christopher; Wilhelmsen Kirk C.; Evans James P.; Earp H. Shelton III; Sharpless Norman E.; Hayes D. Neil; Berg Jonathan S.

首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

【24h】

Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

机译：肿瘤胚线测序二元体的生殖细胞分析，以鉴定可用于临床的次要发现

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To evaluate germline variants in hereditary cancer susceptibility genes among unselected cancer patients undergoing tumor-germline sequencing.

机译：目的：在未选择的接受肿瘤-生殖系测序的癌症患者中，评估遗传性癌症易感性基因的生殖系变异。

著录项

来源
《Clinical cancer research: an official journal of the American Association for Cancer Research》 |2016年第16期|共8页
作者
Seifert Bryce A.; ODaniel Julianne M.; Amin Krunal; Marchuk Daniel S.; Patel Nirali M.; Parker Joel S.; Hoyle Alan P.; Mose Lisle E.; Marron Andrew; Hayward Michele C.; Bizon Christopher; Wilhelmsen Kirk C.; Evans James P.; Earp H. Shelton III; Sharpless Norman E.; Hayes D. Neil; Berg Jonathan S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings [J] . Seifert Bryce A., ODaniel Julianne M., Amin Krunal, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第16期

机译：肿瘤胚线测序二元体的生殖细胞分析，以鉴定可用于临床的次要发现
2. Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests [J] . Christel Thauvin-Robinet, Julien Thevenon, Sophie Nambot, European journal of human genetics: EJHG . 2019,第8期

机译：EXMES测序确定的二级可操作结果：预期对组织治疗的预期影响来自700个连续测试的研究
3. A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing [J] . Berg Jonathan S., Foreman Ann Katherine M., ODaniel Julianne M., Genetics in medicine . 2016,第5期

机译：用于评估基因组规模测序偶然或次要发现的临床可操作性的半定量指标
4. PATH-SCAN: A REPORTING TOOL FOR IDENTIFYING CLINICALLY ACTIONABLE VARIANTS [C] . ROXANA DANESHJOU, ZACHARY ZAPPALA, KIM KUKURBA, Pacific Symposium on Biocomputing . 2014

机译：路径扫描：用于识别临床可操作变体的报告工具
5. An analysis of secondary school leadership literature to identify descriptions of principal behaviors and related conditions serving as blocks to secondary school change. [D] . Warren, James Louis. 1992

机译：对中学领导力文献的分析，以识别对中学变革产生阻碍的主要行为和相关条件的描述。
6. Germline Analysis from Tumor-Germline Sequencing Dyads to identify clinically actionable secondary findings [O] . Bryce A. Seifert, Julianne M. ODaniel, Krunal Amin, -1

机译：肿瘤基因测序测序中的生殖细胞分析以鉴定可用于临床的次要发现
7. Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations [O] . Ecaterina Ileana Dumbrava, Lauren Brusco, Molly S. Daniels, 2019

机译：来自匹配肿瘤/正常测序的次级种系结果的扩展分析鉴定了额外的临床显着突变

Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

摘要

著录项

相似文献

相关主题

期刊订阅